MEAF6 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 6.086000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
6.006200E-01
Normal-vs-Stage2
3.667800E-01
Normal-vs-Stage3
4.249800E-02
Normal-vs-Stage4
7.831400E-01
Stage1-vs-Stage2
2.803600E-02
Stage1-vs-Stage3
3.958500E-02
Stage1-vs-Stage4
7.190600E-01
Stage2-vs-Stage3
1.151400E-01
Stage2-vs-Stage4
1.876760E-01
Stage3-vs-Stage4
4.241800E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
6.259000E-01
Normal-vs-AfricanAmerican
9.510400E-01
Normal-vs-Asian
2.348200E-01
Caucasian-vs-AfricanAmerican
5.586200E-01
Caucasian-vs-Asian
2.582600E-01
AfricanAmerican-vs-Asian
2.164200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
6.127600E-01
Normal-vs-Female
6.045200E-01
Male-vs-Female
7.559200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
4.837400E-01
Normal-vs-Age(41-60Yrs)
9.357800E-01
Normal-vs-Age(61-80Yrs)
4.845200E-01
Normal-vs-Age(81-100Yrs)
3.372300E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
3.351600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
1.421240E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
1.056040E-02
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.615640E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
9.586000E-04
Age(61-80Yrs)-vs-Age(81-100Yrs)
8.171700E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
2.048800E-01
Normal-vs-Daily Drinker
5.606400E-01
Normal-vs-Weekly Drinker
2.662200E-01
Normal-vs-Occasional Drinker
7.563400E-01
Normal-vs-Social Drinker
7.828400E-01
Non Drinker-vs-Daily Drinker
3.475000E-01
Non Drinker-vs-Weekly Drinker
8.886600E-01
Non Drinker-vs-Occasional Drinker
5.244800E-03
Non Drinker-vs-Social Drinker
1.027210E-01
Daily Drinker-vs-Weekly Drinker
5.349200E-01
Daily Drinker-vs-Occasional Drinker
1.028770E-01
Daily Drinker-vs-Social Drinker
5.439600E-01
Weekly Drinker-vs-Occasional Drinker
3.583700E-02
Weekly Drinker-vs-Social Drinker
2.222200E-01
Occasional Drinker-vs-Social Drinker
3.241000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
2.568200E-01
Normal-vs-Grade 2
5.184200E-01
Normal-vs-Grade 3
5.492800E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
4.263400E-01
Grade 1-vs-Grade 3
2.730000E-01
Grade 1-vs-Grade 4
2.568200E-01
Grade 2-vs-Grade 3
4.144000E-01
Grade 2-vs-Grade 4
5.184200E-01
Grade 3-vs-Grade 4
5.492800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
3.806000E-01
Normal-vs-NonDiabetic
6.912800E-01
Diabetic-vs-NonDiabetic
1.751380E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
9.980400E-01
Normal-vs-NoPancreatitis
6.246000E-01
Pancreatitis-vs-NoPancreatitis
3.374800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
6.794600E-01
Normal-vs-N1
3.748800E-01
N0-vs-N1
1.145390E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
5.309800E-01
Normal-vs-TP53-NonMutant
8.278400E-01
TP53-Mutant-vs-TP53-NonMutant
5.069000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
